CD8A and melanoma: For that purpose, we introduced naïve OT1 CD8+ T cells intravenously in mice harboring pre-inflamed subcutaneous B16-VEGFC-OVA melanomas, which present intense lymphatic vascularization and express OT-1 cognate antigen OVA (Supplementary Figure 2A), allowing them to infiltrate tumors for 48 h.